It is crucial to retain the DoCA in order to mainatin the VCR entity, otherwise the PMA will be cancelled by the FDA (applicant entity stops to exist), and the advantage of having the VentrAssist close to marketing approval in the US will be lost.
VCR
ventracor limited
new creditors meeing 3rd july, page-3
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)